This page lists the SEC filings reported by Baker Brothers Advisors.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D | 2021-05-20 | BAKER BROS. ADVISORS LP | Immunocore Holdings plc | 3,352,357 | 7.7% | EDGAR |
| SC 13D/A | 2021-05-18 | BAKER BROS. ADVISORS LP | Seagen Inc. | 47,370,508 | 26.1% | EDGAR |
| SC 13D/A | 2021-05-18 | BAKER BROS. ADVISORS LP | INCYTE CORP | 32,159,373 | 14.6% | EDGAR |
| SC 13G/A | 2021-05-10 | BAKER BROS. ADVISORS LP | Verastem, Inc. | 18,685,695 | 10.9% | EDGAR |
| SC 13G | 2021-04-12 | BAKER BROS. ADVISORS LP | OTONOMY, INC. | 7,220,074 | 14.9% | EDGAR |
| SC 13G/A | 2021-04-09 | BAKER BROS. ADVISORS LP | IDERA PHARMACEUTICALS, INC. | 2,066,535 | 4.9% | EDGAR |
| SC 13D/A | 2021-04-02 | BAKER BROS. ADVISORS LP | Talis Biomedical Corp | 37,432,057 | 67.5% | EDGAR |
| SC 13D/A | 2021-03-19 | BAKER BROS. ADVISORS LP | Aeglea BioTherapeutics, Inc. | 4,901,190 | 9.9% | EDGAR |
| SC 13D/A | 2021-03-05 | BAKER BROS. ADVISORS LP | Kodiak Sciences Inc. | 14,054,698 | 27.4% | EDGAR |
| SC 13D | 2021-03-05 | BAKER BROS. ADVISORS LP | Aeglea BioTherapeutics, Inc. | 4,892,533 | 9.9% | EDGAR |
| SC 13D | 2021-02-26 | BAKER BROS. ADVISORS LP | Talis Biomedical Corp | 37,432,057 | 67.6% | EDGAR |
| SC 13G/A | 2021-02-16 | BAKER BROS. ADVISORS LP | Krystal Biotech, Inc. | 698,874 | 3.5% | EDGAR |
| SC 13G/A | 2021-02-16 | BAKER BROS. ADVISORS LP | CERUS CORP | 13,713,195 | 8.2% | EDGAR |
| SC 13G/A | 2021-02-16 | BAKER BROS. ADVISORS LP | InflaRx N.V. | 856,228 | 3.0% | EDGAR |
| SC 13G/A | 2021-02-16 | BAKER BROS. ADVISORS LP | BIOCRYST PHARMACEUTICALS INC | 18,100,968 | 10.0% | EDGAR |
| SC 13G/A | 2021-02-16 | BAKER BROS. ADVISORS LP | Aeglea BioTherapeutics, Inc. | 4,892,533 | 9.9% | EDGAR |
| SC 13G/A | 2021-02-16 | BAKER BROS. ADVISORS LP | AMARIN CORP PLC | 27,991,761 | 7.2% | EDGAR |
| SC 13G/A | 2021-02-16 | BAKER BROS. ADVISORS LP | MADRIGAL PHARMACEUTICALS, INC. | 1,499,213 | 9.7% | EDGAR |
| SC 13G/A | 2021-02-16 | BAKER BROS. ADVISORS LP | RHYTHM PHARMACEUTICALS, INC. | 2,314,873 | 5.2% | EDGAR |
| SC 13G/A | 2021-02-16 | BAKER BROS. ADVISORS LP | Invitae Corp | 15,774,095 | 8.9% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.